Ethylamine

Ethylamine

SCHEMBL23354591

CC(C)OS(=O)(=O)OC(C)C.CCN

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA9 Q16790 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL560454 0.85 ALDH1A1 (0.59) ALDH1A1CA1CA2CA9
Hydroxyamine SCHEMBL28443903 0.82 ALDH1A1 (0.50) ALDH1A1CA1CA2CA9
SCHEMBL9980900 0.79 ALDH1A1 (0.42) ALDH1A1
Dimethylamine SCHEMBL30080133 0.77 ALDH1A1 (0.50) ALDH1A1CA1CA2CA9
SCHEMBL9980714 0.76 ALDH1A1 (0.43) ALDH1A1CA1CA2CA9
SCHEMBL28493379 0.74
Ammonia Solution, Strong SCHEMBL27951284 0.74 ALDH1A1 (0.42) ALDH1A1CA1CA2CA9
SCHEMBL29133876 0.73 ALDH1A1 (0.53) ALDH1A1CA1CA2CA9
SCHEMBL27494067 0.72
SCHEMBL9980923 0.72 CA1 (0.46) ALDH1A1CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3822259-B1 METHOD FOR SYNTHESIZING VALSARTAN ZHEJIANG HUAHAI PHARM CO LTD (CN) 2025-08-27 EP claimed
US-11434210-B2 Method for synthesizing valsartan ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD (CN) 2022-09-06 US claimed
EP-3822259-A1 METHOD FOR SYNTHESIZING VALSARTAN Zhejiang Huahai Pharmaceutical Co., Ltd. (CN) 2021-05-19 EP claimed
EP-3822259-B1 METHOD FOR SYNTHESIZING VALSARTAN ZHEJIANG HUAHAI PHARM CO LTD (CN) 2025-08-27 EP disclosed
US-11434210-B2 Method for synthesizing valsartan ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD (CN) 2022-09-06 US disclosed
EP-3822259-A1 METHOD FOR SYNTHESIZING VALSARTAN Zhejiang Huahai Pharmaceutical Co., Ltd. (CN) 2021-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11434210-B2 Method for synthesizing valsartan REN, ACE, AGT ALDH1A1 3064/4885CA1 634/4885CA2 275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.